Eliem Therapeutics, Inc. (ELYM)

Eliem Therapeutics Market Cap

Eliem Therapeutics has a market cap or net worth of $228.44 million as of May 17, 2024. Its market cap has increased by 153.26% in one year.

• Market Cap: 228.44M
• Enterprise Value: 123.64M
• 1-Year Change: 153.26%
• Ranking: #3573
• Category: Micro-Cap
• Stock Price: $8.25

Market Cap Chart

Since the IPO on August 10, 2021, Eliem Therapeutics's market cap has decreased from $316.98M to $228.44M, a decrease of -27.93%. That is a compound annual growth rate of -11.15%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	240.00M	0.84%
May 16, 2024	238.00M	2.41%
May 15, 2024	232.40M	2.38%
May 14, 2024	227.00M	-2.62%
May 13, 2024	233.10M	-0.60%
May 10, 2024	234.50M	-5.48%
May 9, 2024	248.10M	-3.95%
May 8, 2024	258.30M	-8.63%
May 7, 2024	282.70M	17.89%
May 6, 2024	239.80M	-14.81%
May 3, 2024	281.50M	21.02%
May 2, 2024	232.60M	10.87%
May 1, 2024	209.80M	6.77%
Apr 30, 2024	196.50M	41.16%
Apr 29, 2024	139.20M	26.20%
Apr 26, 2024	110.30M	17.34%
Apr 25, 2024	94.00M	-7.39%
Apr 24, 2024	101.50M	-2.31%
Apr 23, 2024	103.90M	-3.17%
Apr 22, 2024	107.30M	0.56%
Apr 19, 2024	106.70M	-7.94%
Apr 18, 2024	115.90M	-5.62%
Apr 17, 2024	122.80M	-2.85%
Apr 16, 2024	126.40M	-4.02%
Apr 15, 2024	131.70M	10.21%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
AngioDynamics	242.13M
Akebia Therapeutics	241.04M
Foghorn Therapeutics	238.05M
G1 Therapeutics	236.73M
Aldeyra Therapeutics	235.88M
NeuroPace	235.61M
OptimizeRx	234.22M
908 Devices	232.60M